Sunwin - S1N - A0D9SL
B: Sunwin International Neutraceuticals, Inc.: SUWN Announces 100% Increased Sales of Hypericin Related Products Against Bird Flu Virus ( M2 )
(Comtex 04.05 10:08:18)
Apr 05, 2006 (M2 PRESSWIRE via COMTEX) --
Fort Lauderdale, FL and Qufu, China - Sunwin International
Neutraceuticals, Inc. (OTCBB: SUWN), an industry leader in the
production and distribution of Chinese herbs, veterinary medicines and
low calorie natural sweetener in China, announced continued increases
in sales of Hypericin based products. In November 2005, Sunwin launched
a marketing effort for two products employing Hypericin as a main
component to deter the spread of the avian flu. Since the launch of the
marketing efforts, the combined sales of both products increased from
342,300 RMB per month in November 2005 to 685,800 RMB per month in
February 2006.
Hypericin is a derivative of St. Johns Wort, which is an English word
for a Chinese herb manufactured by Sunwin since 1997. In recent
laboratory tests, Hypericin has proven effective as a treatment for
poultry infected with strands of the avian flu. The in vitro
experiments, performed jointly by the South China Agricultural
University and the Chinese Academy of Agricultural Sciences, indicated
that when H5N1 and H9N2 avian flu viruses were treated with Hypericin
at 3.72 mg/ml for 30 minutes, Hypericin was treating 100% of the
viruses. Furthermore, when these viruses were treated with Hypericin at
0.744 mg/ml for 10 minutes, Hypericin was successful in treating over
99.99% of the viruses.
Sunwin coordinated on a joint project with scientists from the e
Traditional Chinese Medicine department of Shangdong University, the
results were two products which could suppress the spread of certain
strands of the avian flu. The two products are marketed to the
veterinary community in China as a food additive. The products are
mixed with water to feed poultry as a preventative measure to assist in
the efforts to prevent the spread of the avian flu.
In November, 2005 Sunwin announced the Department of Livestock Farming
for Shandong Province Government submitted a fast-track application to
the Livestock Farming Bureau of China Ministry of Agriculture for
approval of Hypericin related products as a class one new veterinary
medicine to treat strands of the avian flu virus. While the China
Ministry of Agriculture has not provided such clearance as a class one
application Sunwin can distribute as a veterinary feed additive within
China.
Laiwang Zhang, President and Chairman of Sunwin International
Neutraceuticals, Inc., stated, "As we await ruling on Hypericin as a
class one veterinary medical application, we launched our two products
for sale as a regular veterinary feed additive. The preliminary
response has been favorable, and we continue to witness steady growth
in sales of these two products. "
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is engaged in
the areas of essential traditional Chi
&a=A0D9SL&zeitraum=5&bname=&ind_news_art=&bis=1144226581&zeitvon=&zeitbis=&cookies=HASH(0xa789254)&ind_volume=ON&von=0&banner_ref=HASH(0xa6e1a50)&req_host=www.ariva.de&b=0&ind_gd38=ON "ariva.de")
